文献速递糖尿病骨质疏松与钙磷/甲状旁腺

2型糖尿病与55岁以上瑞典男女全髋骨面积及骨密度变化的关系

Type 2 Diabetes and Change in Total Hip Bone Area and Bone Mineral Density in Swedish Men and Women Older Than 55 Years.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

该研究基于三个瑞典队列(SMCC、PIVUS、ULSAM),平均8年间重复评估2型糖尿病状态并测量全髋骨面积和骨密度。结果显示,新发2型糖尿病者全髋骨面积增幅较无糖尿病者低0.5%(-0.18 cm²,95%CI -0.30至-0.06),而骨密度变化无显著差异。结论提示新发2型糖尿病与全髋骨面积扩张减少相关。

要点

  • 新发2型糖尿病者全髋骨面积变化较无糖尿病者低0.5%。
  • 现患2型糖尿病者骨面积变化与无糖尿病者相似。
  • 2型糖尿病与全髋骨密度变化无显著关联。

核心结论

  • 新发2型糖尿病者全髋骨面积扩张较无糖尿病者减少。
  • 现患2型糖尿病者骨面积变化与无糖尿病者无差异。
  • 2型糖尿病状态与全髋骨密度变化无显著关联。

研究设计与样本

  • 研究纳入三个瑞典队列:SMCC(n=1060)、PIVUS(n=483)、ULSAM(n=203)。
  • 平均8年间重复评估2型糖尿病状态及双能X线吸收法测量的全髋骨面积和骨密度。
  • 采用线性回归模型评估2型糖尿病状态对骨面积和骨密度变化的影响,并进行荟萃分析。

主要发现

  • 新发2型糖尿病者全髋骨面积变化较无糖尿病者低0.5%(-0.18 cm²;95%CI -0.30至-0.06)。
  • 现患2型糖尿病者全髋骨面积变化与无糖尿病者相似(0.00 cm²;95%CI -0.13至0.13)。
  • 新发2型糖尿病者全髋骨密度变化合并估计值为0.004 g/cm²(95%CI -0.006至0.014)。
  • 现患2型糖尿病者全髋骨密度变化合并估计值为0.010 g/cm²(95%CI -0.000至0.020)。

临床怎么用

  • 对新发2型糖尿病患者,应关注其全髋骨面积扩张减少的可能。
  • 现患2型糖尿病患者的骨面积变化与无糖尿病者相似,无需特殊关注。
  • 2型糖尿病状态不影响全髋骨密度变化,骨密度监测策略可参考常规。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: In a cross-sectional study, we found an association between type 2 diabetes mellitus (T2DM) and smaller bone area together with greater bone mineral density (BMD) at the total hip. OBJECTIVE: This work aims to investigate these associations longitudinally, by studying T2DM status (no T2DM n = 1521, incident T2DM n = 119, or prevalent T2DM n = 106) in relation to changes in total hip bone area and BMD. METHODS: In 3 cohorts, the Swedish Mammography Cohort Clinical (SMCC; n = 1060), Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS; n = 483), and Uppsala Longitudinal Study of Adult Men (ULSAM; n = 203), with repeat assessment of T2DM status and dual energy x-ray absorptiometry (DXA) measurements of total hip bone area and BMD on average 8 years apart, a linear regression model was used to assess the effect of T2DM status on change in bone area and BMD at the total hip. RESULTS: After meta-analysis, the change in bone area at the total hip was 0.5% lower among those with incident T2DM compared to those without T2DM (-0.18 cm2; 95% CI, -0.30 to -0.06). The change in bone area was similar among those with prevalent T2DM compared to those without (0.00 cm2; 95% CI, -0.13 to 0.13). For BMD, the combined estimate was 0.004 g/cm2 (95% CI, -0.006 to 0.014) among those with incident T2DM and 0.010 g/cm2 (95% CI, -0.000 to 0.020) among those with prevalent T2DM, compared to those without T2DM. CONCLUSION: Those with incident T2DM have a lower expansion in bone area at the total hip compared to those without T2DM.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Mitchell A, Fall T, Melhus H, et al. Type 2 Diabetes and Change in Total Hip Bone Area and Bone Mineral Density in Swedish Men and Women Older Than 55 Years. J Clin Endocrinol Metab. 2021. PMID: 34214157. doi:10.1210/clinem/dgab490

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。